Bank of America
ORGO icon

Bank of America’s Organogenesis Holdings ORGO Stock Holding History

Bank of America’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.37M Buy
563,048
+14,786
+3% +$36.1K ﹤0.01% 4455
2026
Q1 		$1.3M Buy
548,262
+22,452
+4% +$77.8K ﹤0.01% 4377
2025
Q4 		$2.72M Sell
525,810
-85,875
-14% -$416K ﹤0.01% 3825
2025
Q3 		$2.58M Buy
611,685
+130,875
+27% +$608K ﹤0.01% 4599
2025
Q2 		$1.76M Sell
480,810
-20,218
-4% -$75.4K ﹤0.01% 4889
2025
Q1 		$2.16M Sell
501,028
-18,086
-3% -$73K ﹤0.01% 4610
2024
Q4 		$1.66M Buy
519,114
+19,506
+4% +$65.4K ﹤0.01% 4609
2024
Q3 		$1.43M Buy
499,608
+3,068
+0.6% +$8.6K ﹤0.01% 4816
2024
Q2 		$1.39M Buy
496,540
+11,643
+2% +$31.2K ﹤0.01% 4693
2024
Q1 		$1.38M Sell
484,897
-67,029
-12% -$228K ﹤0.01% 4719
2023
Q4 		$2.26M Buy
551,926
+22,590
+4% +$63.3K ﹤0.01% 4287
2023
Q3 		$1.68M Buy
529,336
+11,965
+2% +$38K ﹤0.01% 4418
2023
Q2 		$1.72M Buy
517,371
+451,990
+691% +$1.34M ﹤0.01% 4345
2023
Q1 		$139K Sell
65,381
-21,083
-24% -$52.1K ﹤0.01% 6112
2022
Q4 		$233K Sell
86,464
-2,043
-2% -$5.96K ﹤0.01% 5834
2022
Q3 		$286K Sell
88,507
-235,661
-73% -$1.06M ﹤0.01% 5762
2022
Q2 		$1.58M Buy
324,168
+59,219
+22% +$365K ﹤0.01% 4503
2022
Q1 		$2.02M Sell
264,949
-69,475
-21% -$538K ﹤0.01% 4578
2021
Q4 		$3.09M Buy
334,424
+215,447
+181% +$2.29M ﹤0.01% 4124
2021
Q3 		$1.69M Buy
118,977
+102,364
+616% +$1.59M ﹤0.01% 4596
2021
Q2 		$276K Buy
16,613
+437
+3% +$8.15K ﹤0.01% 5848
2021
Q1 		$295K Buy
16,176
+10,221
+172% +$138K ﹤0.01% 5761
2020
Q4 		$45K Buy
5,955
+4,995
+520% +$23.7K ﹤0.01% 6364
2020
Q3 		$4K Sell
960
-2,603
-73% -$10.3K ﹤0.01% 6619
2020
Q2 		$14K Buy
3,563
+2,138
+150% +$7.71K ﹤0.01% 6349
2020
Q1 		$4K Sell
1,425
-822
-37% -$3.52K ﹤0.01% 6534
2019
Q4 		$11K Sell
2,247
-2,887
-56% -$18.3K ﹤0.01% 6631
2019
Q3 		$33K Buy
5,134
+3,042
+145% +$16.9K ﹤0.01% 6459
2019
Q2 		$16K Sell
2,092
-3,478
-62% -$25.6K ﹤0.01% 6621
2019
Q1 		$42K Buy
+5,570
New +$111K ﹤0.01% 6264

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Bank of America's ORGO Position: Q2 2026 in Review

Bank of America increased its Organogenesis Holdings (ORGO) stake by 2.7% in Q2 2026, buying an estimated $36.1K and bringing the position to 563,048 shares worth $1.37M. The position accounts for ﹤0.01% of the portfolio, ranked #4455.

Bank of America first reported a position in ORGO in Q1 2019 and has held it in 30 quarters since. The position peaked at $3.09M in Q4 2021. 134 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Bank of America held 563,048 shares of Organogenesis Holdings worth $1.37M as of Q2 2026.
  • Bank of America bought 14,786 Organogenesis Holdings shares in Q2 2026, an estimated $36.1K.
  • Organogenesis Holdings made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #4455 holding.
  • Bank of America first reported a position in Organogenesis Holdings in Q1 2019 and has held it in 30 quarters since.
  • Bank of America's Organogenesis Holdings position peaked at $3.09M in Q4 2021.
  • 134 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.